About Shiv

Dr. Shiv Kumar Sarin obtained his M.B.,B.S. degree with seven gold medals (1974), his MD in General Medicine (1978) from Rajasthan University, and his Fellowship in Gastroenterology from the All India Institute of Medical Sciences, in 1981. He served at the G.B. Pant Hospital, University of Delhi in 1983, becoming the Director Professor and Head of Gastroenterology in 1997. He is currently the Senior Professor and Head, Department of Hepatology and Director, Institute of Liver and Biliary Sciences. He is also the Director, WHO collaborative center on Viral hepatitis and Liver Diseases at ILBS, New Delhi India. He serves as Adjunct Faculty, Molecular Medicine at JNU due to his deep interest and contributions to translational science.

His research interests include Portal hypertension, Chronic hepatitis B, C, Liver regeneration, Acute-on-chronic Liver Failure and Liver cancer. During his academic career spanning 35 years, Prof. Sarin contributed immensely to the field of Hepatology. These include “Sarin’s Classification of Gastric Varices”; variceal band ligation as primary prophylaxis which was a landmark NEJM paper;. He defined new disease entities, portal biliopathy and acute and chronic liver failure His seminal contributions on liver regeneration using growth factors have the potential for providing non-transplant options to ACLF patients. He has more than 475 publications, helped develop 18 major guidelines and edited 13 books. He is the founding Co-Chief Editor of Hepatology International. He started the APASL School of Hepatology and was instrumental in setting up a Dedicated Liver University, the Institute of Liver and Biliary Sciences (ILBS) in India. ILBS was recently designated as the first WHO Collaborative Center globally in Liver Diseases.

Prof. Sarin has been bestowed with Padma Bhushan (third highest civilian award of the country) by the Govt of India. He is a member of all the three science academies of the country. He has been a recipient of Shanti Swarup Bhatnagar award, the highest Award in Science in India, The World Academy of Medical Sciences International Prize, EASL International Recognition Award and ‘Most Distinguished Physician from India” from the American Association of Physicians of India, Fograty Fellowship of the NIH to work at University of Yale, and Senior Fellowship of the Japanese Society for Promotion of Science to work at Chiba, Japan.

He was instrumental in setting up the Institute of Liver and Biliary Sciences (ILBS), under the auspices of the Govt of Delhi. ILBS has been conferred the status of a Deemed-to be University by the Govt. of India and is the first dedicated ‘Liver University’, globally. ILBS has been designated as the first WHO Collaborative Center in the world in the field of Liver Diseases.

Prof. Sarin has shown leadership roles in being the President of the Indian Society of Gastroenterology, Indian Association for the Study of the Liver, Asian Pacific Association of Liver (APASL), Vice President of International Association for Surgeons, Gastroenterologists and Oncologists, and the Chairman Steering Committee of the APASL.

Prof. Sarin was nominated to lead the Medical Council of India (MCI) as the Chairman of the Board of Governors, 2010-2011. He developed the ‘Vision 2015’ document for Medical Education in India and had introduced far reaching reforms.

This speaker will be presenting at the following session(s)

  • Liver societies' role towards viral hepatitis elimination


    Day: 2 November

    Time: 08:00

    Topics to be discussed:

    • Prevention of mother to child transmission of HBV and strategies to increase HBV vaccine coverage (in particular birth dose coverage) and antiviral therapy for highly viremic HBsAg+ mothers.
    • Improving diagnosis of persons chronically infected with HBV or HCV.
    • Improving linkage to care of persons diagnosed to have chronic HBV or HCV, in particular vulnerable populations and persons living in rural areas.
    • Improving access to antiviral treatment of persons with chronic HBV or HCV.